Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.91% |
| 2 | Technology | 7.43% |
| 3 | Financials | 6.52% |
| 4 | Consumer Discretionary | 5.69% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VNE
1326
DELISTED
Veoneer, Inc.
VNE
| $4.82M | 0.01% |
659,034
+134,976
| +26% | +$1.61M |
|
1327
California Water Service
CWT
$3.14B
| $4.82M | 0.01% |
95,854
+36,291
| +61% | +$1.88M |
|
1328
VeriSign
VRSN
$26.3B
| $4.82M | 0.01% |
26,764
-114,236
| -81% | -$22.5M |
|
1329
Keurig Dr Pepper
KDP
$44.2B
| $4.81M | 0.01% |
198,230
-153,545
| -44% | -$4.14M |
|
|
EVRI
1330
DELISTED
Everi Holdings
EVRI
| $4.81M | 0.01% |
1,457,331
-387,661
| -21% | -$3.95M |
|
1331
Pentair
PNR
$10.1B
| $4.8M | 0.01% |
161,412
+18,384
| +13% | +$739K |
|
|
RARX
1332
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $4.8M | 0.01% |
100,043
-521,123
| -84% | -$24.2M |
|
|
MRO
1333
DELISTED
Marathon Oil Corporation
MRO
| $4.8M | 0.01% |
1,459,387
+1,267,985
| +662% | +$11.7M |
|
1334
Gyre Therapeutics
GYRE
$683M
| $4.8M | 0.01% |
146,378
+50,729
| +53% | +$2.33M |
|
1335
Opko Health
OPK
$1.1B
| $4.79M | 0.01% |
3,571,399
+2,676,774
| +299% | +$4.19M |
|
1336
Kura Oncology
KURA
$1.1B
| $4.78M | 0.01% |
480,718
-149,009
| -24% | -$1.71M |
|
|
PRNB
1337
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $4.78M | 0.01% |
+80,484
| New | +$4.69M |
|
1338
CALL
Lam Research
LRCX
$388B
| $4.78M | 0.01% |
199,000
-41,000
| -17% | -$1.18M |
|
|
CCH.WS
1339
CALL
DELISTED
Collier Creek Holdings Warrants, each whole warrant exercisable for one Class A ordinary share at an
CCH.WS
| $4.77M | 0.01% |
+466,666
| New | +$793K |
|
1340
Shopify
SHOP
$193B
| $4.77M | 0.01% |
114,350
+107,160
| +1,490% | +$4.83M |
|
1341
BlackLine
BL
$1.86B
| $4.77M | 0.01% |
90,616
-449,344
| -83% | -$26.3M |
|
|
APTO
1342
DELISTED
Aptose Biosciences, Inc.
APTO
| $4.77M | 0.01% |
1,783
-62
| -3% | -$185K |
|
|
CUK
1343
DELISTED
Carnival PLC
CUK
| $4.76M | 0.01% |
398,664
+149,349
| +60% | +$5M |
|
1344
Zillow
Z
$8.33B
| $4.74M | 0.01% |
131,657
+124,374
| +1,708% | +$5.74M |
|
1345
Gilead Sciences
GILD
$182B
| $4.74M | 0.01% |
63,410
-1,251,286
| -95% | -$86.5M |
|
1346
Iovance Biotherapeutics
IOVA
$3.65B
| $4.73M | 0.01% |
+157,930
| New | +$4.19M |
|
1347
Fluor
FLR
$6.86B
| $4.72M | 0.01% |
683,817
-1,212,507
| -64% | -$16.9M |
|
1348
CALL
iShares MSCI Brazil ETF
EWZ
$8.07B
| $4.71M | 0.01% |
200,000
| – | – |
|
1349
SM Energy
SM
$8.67B
| $4.71M | 0.01% |
3,858,571
+3,104,684
| +412% | +$22M |
|
1350
Hecla Mining
HL
$13.7B
| $4.7M | 0.01% |
2,581,848
-1,113,055
| -30% | -$3.08M |
|
Similar funds
Israel Englander's Q1 2020 Portfolio in Review
As of Q1 2020, Israel Englander held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Danaher worth $133M.
- Israel Englander's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Israel Englander added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Israel Englander's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Israel Englander fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Israel Englander opened 789 new positions and closed 1,154 in Q1 2020.
- Israel Englander's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.